Delivery Order SPE2DB24D9238-SPE2DB25FDQYB
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,510.63 for EXPAREL 1.3% 20ML (10 units) on July 22, 2025. The award was made by the Defense Logistics Agency's Medical Supply Chain on a firm fixed-price basis with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,063.78 by the Defense Logistics Agency on July 25, 2025, for the supply of EXPAREL 266 mg/20 ml vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and carries no set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on July 24, 2025, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order, valued at $50,212.60, is set to be completed by August 14, 2025, with performance taking place at the company's Park Ridge location. The award carries no set-aside designation, reflecting the contractor's competitive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $5,021.26 for EXPAREL 1.3% 20ML (10 units) by the Defense Logistics Agency's Medical Supply Chain. The contract was awarded on July 31, 2025, with an ultimate completion date of the same day, and carries no set-aside designation. EXPAREL is a liposomal bupivacaine formulation used for local anesthesia and...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at approximately $25.1K for EXPAREL 266 mg/20 mL vials. This award was issued as a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its small business status. EXPAREL is...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award valued at $5,021.26 from the Defense Logistics Agency's Medical Supply Chain for EXPAREL 1.3% 20ML (10 units). This firm fixed-price delivery order, awarded on August 4, 2025, with an ultimate completion date of August 4, 2025, represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on July 24, 2025, for EXPAREL 133 mg/10 mL vials. The contract is valued at $1,707.02 and is classified as a firm fixed-price delivery order with an ultimate completion date of August 14, 2025. The award carries no set-aside designation, and the place of performance is located in Park Ridge, Illinois. This...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,021.26 by the Defense Logistics Agency (DLA) on July 24, 2025, with an ultimate completion date of August 14, 2025. The delivery order is for EXPAREL 266 mg/20 ml vials, a local anesthetic medication used in surgical and pain management applications. This award was issued without a set-aside designation, allowing the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,531.89 to DMS Pharmaceutical Group Inc. for the supply of EXPAREL 266 mg/20 mL vials. The award, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, does not utilize a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this delivery order at its Park Ridge location. This delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,510.63 by the Defense Logistics Agency on July 24, 2025, for the supply of Exparel 266 mg/20 ml vials. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a discrete purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA. The award carries no set-aside...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDQYBDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order from the Defense Logistics Agency valued at $5,021.26 for EXPAREL 266 mg/20 mL vials. This award, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, was made without a set-aside designation. The delivery order falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.9 billion contract vehicle valid through November 2026 that enables the agency to procure pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide. EXPAREL is a liposomal bupivacaine formulation used for infiltration and nerve block anesthesia in surgical settings. This delivery order represents a routine procurement of the pharmaceutical product to maintain the medical supply chain for military healthcare operations. DMS Pharmaceutical Group has established itself as a key supplier in federal pharmaceutical procurement through consistent contract awards from the Defense Logistics Agency, with a portfolio spanning prescription medications, biologics, vaccines, and specialty pharmaceutical products for military and federal healthcare systems nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 8/4/25 |